Use of type v phosphodiesterase inhibitors in the treatment...

Details Use of type v phosphodiesterase inhibitors in the treatment... Use of type v phosphodiesterase inhibitors in the treatment...

A - Human Necessities

61

K

A61K 31/496 (2006.01) A61K 31/497 (2006.01) A61P 7/04 (2006.01) A61P 11/00 (2006.01) A61D 7/00 (2006.01)

Patent

CA 2651086

The use of type V phosphodiesterase inhibitors as a novel independent therapeutic modality in the treatment of exercise induced pulmonary hemorrhage in equine is described. The type V phosphodiesterase inhibitor is injected into the horse intravenously as a stand-alone agent from about one-half hour to about seven (7) days prior to the onset of strenuous exercise.

L'invention concerne l'utilisation d'inhibiteurs de la phosphodiestérase de type V comme nouvelle modalité thérapeutique indépendante dans le traitement une hémorragie pulmonaire induite par l'exercice chez le cheval. L'inhibiteur de phosphodiestérase de type V est injecté au cheval par voie intraveineuse sous la forme d'un agent indépendant environ une demi-heure à environ sept (7) jours avant le début d'un effort intense.

Affiliated with

Also associated with

Rating

Use of type v phosphodiesterase inhibitors in the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of type v phosphodiesterase inhibitors in the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of type v phosphodiesterase inhibitors in the treatment... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1788710